Drugs News and Research

RSS

Gates Foundation leads the charge against tuberculosis with Northeastern University

Northeastern University announced that Dr. Kim Lewis, Professor of Biology and Director of the Antimicrobial Center, is among the recipients of $280 million in grants the Bill & Melinda Gates Foundation has dedicated to help support the research and speed the development of TB vaccines, diagnostic tests, and treatments.

4 Oct 2007

Donepezil no better than placebo to treat behavioural symptoms of Alzheimer's

New research has found that donepezil (known commercially as Aricept©) is no more effective than a placebo at tackling the agitation which often accompanies Alzheimer's disease.

4 Oct 2007

Specific immune deficiency pinpointed as likely cause of ulcerative colitis

In a series of mouse experiments, researchers at the Harvard School of Public Health (HSPH) have pinpointed a specific immune deficiency as the likely fundamental cause of ulcerative colitis, a chronic, sometimes severe inflammatory disease of the colon or large intestine that afflicts half a million Americans.

4 Oct 2007

New findings on cholesterol metabolism in the brain and Alzheimer's disease

Although the causes of Alzheimer's disease are not completely understood, amyloid-beta (A-beta) is widely considered a likely culprit - the "sticky" protein clumps into plaques thought to harm brain cells.

4 Oct 2007

Cell's cytoskeleton may hold key to overcoming drug resistance in cancer

Researchers have uncovered a new way in which a cell protein protects cancer cells from a wide range of chemotherapeutic drugs, identifying a possible target for improving treatment outcomes for patients.

4 Oct 2007

Bilberry extract for cancer prevention

A Leicester cancer research project, which receives funding from Hope Against Cancer (formerly The Hope Foundation,) is investigating whether an extract from bilberries can prevent or delay the onset of certain cancers.

4 Oct 2007

Osteoarthritis drug Prexige withdrawn from Canadian market

Health authorities in Canada have withdrawn the osteoarthritis drug Prexige from the market amid concerns the drug increases the risk for serious liver-related damage including hepatitis.

4 Oct 2007

New FDA program will fast forward generic drug approvals

The Food and Drug Administration (FDA) in the United States has a plan to fast forward it's approval process for generic drugs.

4 Oct 2007

Individually tailored herbal concoctions possibly harmful

Scientists in Britain are warning that there is no evidence to suggest herbal medicines "tailored" to the individual do actually work; they also say such concoctions may even be harmful.

4 Oct 2007

New targeted approach to pain management

Imagine an epidural or a shot of Novocain that doesn't paralyze your legs or make you numb, yet totally blocks your pain.

4 Oct 2007

Infant mortality rates decline in New York City

New York City's infant mortality rate - widely regarded as a barometer of a population's general health - fell slightly in 2006, the Health Department reported today.

4 Oct 2007

Cancer trial combines multiple drugs to attack blood vessel formation in patients with kidney cancer

In the first clinical trial of its kind, researchers at the University of Pennsylvania School of Medicine and the Abramson Cancer Center will lead a nationwide test of anti-cancer drug combinations that target blood vessel growth in patients with advanced kidney cancer.

4 Oct 2007

Linking two molecular pieces may offer new approaches to treating Alzheimer's disease

Researchers have uncovered a biological link between the protein whose mutation causes early-onset Alzheimer's disease (AD) and a gene variant linked to late-onset AD.

4 Oct 2007

Isis Pharmaceuticals awarded $1.5 million NIH grant to improve RNAi-based therapeutics

Isis Pharmaceuticals, Inc. has announced that it has been awarded a multi-year Phase 2 Small Business Innovation Research (SBIR) grant by the National Institutes of Health (NIH) for up to $1.5 million to design oligonucleotide drugs that can exploit the RNA interference (RNAi) antisense mechanism for disease treatment.

4 Oct 2007